Polaris Group (TPE: 6550)
Taiwan
· Delayed Price · Currency is TWD
47.20
+1.45 (3.17%)
Jan 6, 2025, 1:30 PM CST
Polaris Group Company Description
Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services.
The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications.
It also provides healthcare consulting, staffing, and MDS solutions. The company was founded in 1988 and is based in Tampa, Florida.
Polaris Group
Country | Cayman Islands |
Founded | 1988 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 165 |
CEO | Steve Hsu |
Contact Details
Address: 3030 N. Rocky Point Drive Tampa, 33607 United States | |
Phone | 813 886 6500 |
Website | polaris-group.com |
Stock Details
Ticker Symbol | 6550 |
Exchange | Taiwan Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
ISIN Number | KYG7171A1085 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Dr. Steve J.P. Hsu | Chief Executive Officer |
Jack Fitzgibbons | President |
Ray Wu | Chief Financial Officer |
Chien-Hsing Chang | Chief Strategy Officer |
Kevin Wu | Chief Information Security Officer |